Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Blood|October 24, 2009
AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasmsYe Ding, Yuka Harada, Jun Imagawa, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 5, 2004
[Drug-resistant B cell chronic lymphocytic leukemia safely treated with rituximab to control leukemic cell increment and platelet transfusion dependence]Jun Imagawa, Hiromasa Nimi, Yuta Katayama, et al.International Journal of Hematology|July 17, 2012
A sharp fluctuation in peripheral blood cells shortly after dasatinib administrationJun Imagawa, Hideo Tanaka, Kana Matsumoto, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 2012
[Successful treatment with bortezomib for a patient with plasma cell leukemia accompanied by severe hyperbilirubinemia]Tatsuji Mino, Akira Sakai, Miki Kinoshita, et al.Blood|September 24, 2010
Clinical and genetic features of therapy-related myeloid neoplasms after chemotherapy for acute promyelocytic leukemiaJun Imagawa, Yuka Harada, Takeshi Shimomura, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 9, 2011
[Successful treatment with low-dose dasatinib in a patient with chronic eosinophilic leukemia intolerant to imatinib]Jun Imagawa, Yuka Harada, Tetsumi Yoshida, et al.International Journal of Hematology|June 29, 2004
Progressive myeloma after thalidomide therapy in a patient with immature phenotype of myeloma (plasma) cellsYoshiko Okikawa, Akira Sakai, Yasuo Takimoto, et al.International Journal of Hematology|May 26, 2005
The maturation of myeloma cells correlates with sensitivity to chemotherapeutic agentsYoshiaki Kuroda, Akira Sakai, Yoshiko Okikawa, et al.Blood|March 9, 2013
RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromesYuka Harada, Daichi Inoue, Ye Ding, et al.Blood Advances|April 5, 2019
NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesisYoshihiro Hayashi, Yuka Harada, Yuki Kagiyama, et al.Pageof 2